Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated.

Slides:



Advertisements
Similar presentations
Antibiotic treatment patterns across Europe in patients with complicated skin and soft- tissue infections due to meticillin-resistant Staphylococcus aureus:
Advertisements

Clinical Microbiology and Infection
Gram-positive infections: lessons learnt and novel solutions
Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus.
Clinical Microbiology and Infection
Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors  S. Amit, H. Mishali, T. Kotlovsky,
Clinical Microbiology and Infection
Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections 
I. López-Hernández, M. Delgado Valverde, N. Batista Díaz, A. Pascual 
M.F.Q. Kluytmans-VandenBergh, J.A.J.W. Kluytmans 
Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience  H. Asgeirsson, A. Thalme, M. Kristjansson,
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to.
Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis  T. Steinmetz, N.
European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years.
The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria  M.J. Rybak  Clinical Microbiology and Infection 
Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010–2011): assessment of clinical practice.
European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.
Vancomycin treatment is a risk factor for vancomycin-nonsusceptible Staphylococcus capitis sepsis in preterm neonates  M. Butin, J.-P. Rasigade, F. Subtil,
Clinical impact of antibiotic-resistant Gram-positive pathogens
Cost-effectiveness of universal MRSA screening on admission to surgery
Clonal complex 398 methicillin-susceptible Staphylococcus aureus bloodstream infections are associated with high mortality  K. Bouiller, H. Gbaguidi-Haore,
European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.
Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals 
Clinical impact and prevalence of MRSA CC398 and differences between MRSA-TetR and MRSA-TetS in an area of Spain with a high density of pig farming: a.
Longitudinal investigation of nasopharyngeal methicillin-resistant Staphylococcus aureus colonization in early infancy: The PATCH birth cohort study 
J.-P. Stahl  Clinical Microbiology and Infection 
Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?  M. Paul, N. Zemer-Wassercug, O.
Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012  V.
Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit  K. Thorburn,
W. Witte, B. Pasemann, C. Cuny  Clinical Microbiology and Infection 
L.R. Peterson  Clinical Microbiology and Infection 
Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals  C. Nonhoff, O. Denis,
A variant of the Southern German clone of methicillin-resistant Staphylococcus aureus is predominant in Croatia  A. Budimir, R.H. Deurenberg, Z. Bošnjak,
Bacterial resistance—the clinical challenge
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia  M. Bassetti, E.M. Trecarichi, A. Mesini,
Strategies for managing today's infections
Panton–Valentine leukocidin-positive Staphylococcus aureus skin and soft tissue infections among children in an emergency department in Madrid, Spain 
Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections—a systematic review and meta-analysis  R. Diaz, V. Afreixo,
Population structure analyses of Staphylococcus aureus at Tygerberg Hospital, South Africa, reveals a diverse population, a high prevalence of Panton–Valentine.
Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections 
Transmissibility of livestock-associated methicillin-resistant Staphylococcus aureus (ST398) in Dutch hospitals  M.W.M. Wassenberg, M.C.J. Bootsma, A.
M. Aires-de-Sousa  Clinical Microbiology and Infection 
Systematic review of antibiotic consumption in acute care hospitals
Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to.
B. Y. Lee, A. Singh, M. Z. David, S. M. Bartsch, R. B. Slayton, S. S
Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals  G.L. Cartolano,
A.W. Karchmer  Clinical Microbiology and Infection 
P.M. Hawkey  Clinical Microbiology and Infection 
Increased incidence of methicillin-resistant Staphylococcus aureus ST80, novel ST125 and SCCmecIV in the south-eastern part of Norway during a 12-year.
Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan 
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
G.M. Rossolini, E. Mantengoli  Clinical Microbiology and Infection 
P. Kaltsas, S. Want, J. Cohen  Clinical Microbiology and Infection 
J.-M. Rolain, C. Abat, P. Brouqui, D. Raoult 
Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin.
D. Nathwani, W. Lawson, M. Dryden, J. Stephens, S. Corman, C. Solem, J
Predictors of clinical and microbiological treatment failure in patients with methicillin- resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective.
Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search.
E. Tacconelli  Clinical Microbiology and Infection 
J. Wilson, S. Elgohari, D. M. Livermore, B. Cookson, A. Johnson, T
A. Manzur, F. Gudiol  Clinical Microbiology and Infection 
W. Witte  Clinical Microbiology and Infection 
B.A. Cunha  Clinical Microbiology and Infection 
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of source of infection and vancomycin AUC0–24/MICBMD targets on treatment failure in patients with methicillin-resistant Staphylococcus aureus.
D.A. Robinson, M.C. Enright  Clinical Microbiology and Infection 
Impact of a targeted isolation strategy at intensive-care-unit-admission on intensive- care-unit-acquired infection related to multidrug-resistant bacteria:
CMI readers' survey Clinical Microbiology and Infection
Presentation transcript:

Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus  C. Eckmann, D. Nathwani, W. Lawson, S. Corman, C. Solem, J. Stephens, C. Macahilig, J. Li, C. Charbonneau, N. Baillon-Plot, S. Haider  Clinical Microbiology and Infection  Volume 21, Pages S33-S39 (September 2015) DOI: 10.1016/j.cmi.2015.01.011 Copyright © 2015 Terms and Conditions

Fig. 1 Cohort selection for patient subgroup with methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft-tissue infections and peripheral vascular disease (PVD) and/or diabetes. Clinical Microbiology and Infection 2015 21, S33-S39DOI: (10.1016/j.cmi.2015.01.011) Copyright © 2015 Terms and Conditions

Fig. 2 Hospital length of stay in patients with methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections and peripheral vascular disease and/or diabetes receiving vancomycin or linezolid (propensity-score weighted). HDU, high-dependency unit; ICU, intensive care unit. Clinical Microbiology and Infection 2015 21, S33-S39DOI: (10.1016/j.cmi.2015.01.011) Copyright © 2015 Terms and Conditions

Fig. 3 Total and intravenous length of treatment in patients with methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections and peripheral vascular disease and/or diabetes receiving vancomycin or linezolid (propensity-score weighted). Clinical Microbiology and Infection 2015 21, S33-S39DOI: (10.1016/j.cmi.2015.01.011) Copyright © 2015 Terms and Conditions

Fig. 4 Hospital length of stay in patients with methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections and peripheral vascular disease receiving vancomycin or linezolid (propensity-score weighted). HDU, high dependency unit; ICU, intensive care unit. Clinical Microbiology and Infection 2015 21, S33-S39DOI: (10.1016/j.cmi.2015.01.011) Copyright © 2015 Terms and Conditions